ATC Group: J06BB02 Tetanus immunoglobulin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J06BB02 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J06 Immune sera and immunoglobulins
3 J06B Immunoglobulins
4 J06BB Specific immunoglobulins
5 J06BB02 Tetanus immunoglobulin

Active ingredients in J06BB02

Active Ingredient Description
Tetanus immunoglobulin

Human tetanus immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against the toxin produced by the bacteria clostridium tetanus.

Related product monographs

Title Information Source Document Type  
HYPERTET Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
TETAGAM-P Solution for injection Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Austria (AT)

Brazil (BR)

Canada (CA)

Ecuador (EC)

Estonia (EE)

France (FR)

Hong Kong (HK)

Ireland (IE)

Malta (MT)

Netherlands (NL)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.